• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 12, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

MicroMesh: a microscopic polymeric network to attack glioblastoma multiforme

Bioengineer by Bioengineer
April 19, 2021
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers at Istituto Italiano di Tecnologia in collaboration with Stanford Medicine and the San Raffaele Hospital have demonstrated with preclinical studies the effectiveness of a new biomedical implant for the treatment of glioblastoma multiforme

IMAGE

Credit: D. Beghetto/IIT

Genova (Italy), 16th April 2021 – A micro-sized polymeric net wrapping around brain tumors, just like a fishing net around a shoal of fish: this is the microMESH, a new nanomedicine device capable to conform around the surface of tumor masses and efficiently deliver drugs. It has been described by the researchers of the IIT – Istituto Italiano di Tecnologia (Italian Institute of Technology) in Nature Nanotechnology. The new biomedical implant has been validated in preclinical studies that demonstrate its effectiveness for the treatment of glioblastoma multiforme.

This work has been carried out by the group of Prof. Paolo Decuzzi, head of the IIT Laboratory of Nanotechnology for Precision Medicine, in collaboration with the Neural Stem Cell Biology Laboratory of Dr. Rossella Galli at the San Raffaele Hospital in Milan and the group of Prof. Gerald Grant at the Lucile Packard Children’s Hospital of Stanford University. The study was originated within the research activities conducted by Decuzzi in the context of projects supported by the European Research Council and the Marie Sk?odowska-Curie Action program.

Although they are quite rare, brain tumors are among the most aggressive and difficult to cure. In particular, glioblastoma multiforme is the tumor with the most severe prognosis: the average survival is just over 12 months and only 5% of the patients survive beyond 5 years. Glioblastoma multiforme typically affects men and women between 45 and 75 years of age. Furthermore, unlike other malignancies, there has been no significant diagnostic and therapeutic improvements for this malignancy over the past 30 years. In fact, both the incidence of new cases and the number of deaths has remained practically unchanged. The only therapeutic strategy currently used is based on surgery, which consists of removing a part of the tumor mass and reducing intracranial pressure, followed by radiotherapy and/or chemotherapy.

The biomedical system developed by IIT and its collaborators can play a very important role in the fight against the disease, representing a possible effective alternative to the few pharmacological treatments used to date.

The microMESH has the shape of a micrometric polymeric net, it is made with biodegradable materials and wraps around the tumor mass. In fact, the micrometric thick polymeric fibers are very flexible and are arranged to form regular openings, which are also micrometric, just like the size of cancer cells. This unique feature allows the microMESH to achieve a closer interaction with the tumor mass, increasing the therapeutic efficacy. Its structure consists of two separate compartments in which different drugs can be loaded which are released towards the tumor mass in an independent, precise, and prolonged fashion. The microMESH can ‘attack’ glioblastoma by combining different therapies: chemotherapy, nanomedicine, and immunotherapy.

Prof. Paolo Decuzzi and his collaborators, in particular Daniele Di Mascolo and Anna Lisa Palange, will continue to develop the microMESH by integrating different types of drugs and therapies to tackle other types of tumors. In the short term, their major objective will be to validate the technology on glioblastoma patients.

###

Media Contact
Valeria delle Cave
valeria.dellecave@iit.it

Related Journal Article

http://dx.doi.org/10.1038/s41565-021-00879-3

Tags: cancerMedicine/HealthNanotechnology/MicromachinesResearch/DevelopmentTechnology Transfer
Share12Tweet8Share2ShareShareShare2

Related Posts

Sundarbans polyhaline soils show low to moderate heavy metal contamination

Sundarbans polyhaline soils show low to moderate heavy metal contamination

November 12, 2026
Soil PM10 Analysis Helps Distinguish Transport Contamination From Lithogenic Soil Elements

Soil PM10 Analysis Helps Distinguish Transport Contamination From Lithogenic Soil Elements

November 12, 2026

Turnstile Metal-Organic Framework Separates Cyclohexene and Cyclohexane via Orientational Locking

November 12, 2026

Pumpkin Seed Protein Creamer Smooths Coffee While Preserving Natural Flavor

November 12, 2026
Please login to join discussion

POPULAR NEWS

  • Osteopontin Alleviates Early Brain Injury by Guiding Macrophages in Rat Model

    Osteopontin Alleviates Early Brain Injury by Guiding Macrophages in Rat Model

    29 shares
    Share 12 Tweet 7
  • Prenatal Mycoestrogen Exposure Linked to Lower Early Childhood Cognition in Girls

    29 shares
    Share 12 Tweet 7
  • USP7 Inhibition Suppresses Endothelial Ferroptosis and Alleviates Atherosclerosis in Laboratory Models

    29 shares
    Share 12 Tweet 7
  • Theoretical Framework Combines Electronic Nicotine Delivery With Mobile Therapy for Smoking Cessation

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sundarbans polyhaline soils show low to moderate heavy metal contamination

Hybrid Network Improves Digital Rock Image Resolution While Preserving Critical Petrophysical Properties

Ubiquitin Ligases MKRN1, MKRN2, and RNF214 Drive Stress Granule Clearance in Cultured Human Cells

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.